Rikje Ruiter

Reference values for white blood-cell-based inflammatory markers in the Rotterdam Study: a population-based prospective cohort study

Jesse Fest, Rikje Ruiter, M. Arfan Ikram et al. · Scientific Reports · 2018 · 287 citations · Full text

Medicine, Hematology, Immunology +14

Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives

Rikje Ruiter, Loes E. Visser, Myrthe P. P. van Herk‐Sukel et al. · Diabetes Care · 2011 · 233 citations · Full text

Medicine, Oncology, Pharmacology +13

The systemic immune‐inflammation index is associated with an increased risk of incident cancer—A population‐based cohort study

Jesse Fest, Rikje Ruiter, Marlies Mulder et al. · International Journal of Cancer · 2019 · 176 citations · Full text

Medicine, Immunology, Oncology +15

Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis

Daniel L. Levin, Samira Bell, Reijo Sund et al. · Diabetologia · 2014 · 155 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Thyroid Function and Cancer Risk: The Rotterdam Study

Samer R. Khan, Layal Chaker, Rikje Ruiter et al. · The Journal of Clinical Endocrinology & Metabolism · 2016 · 147 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16